Regulus Therapeutics (RGLS)

0.70 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/31/18 *Est.)

Latest Headlines

Form 8-K Regulus Therapeutics For: Jun 01 June 5, 2018 5:02 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: Witz Pascale June 5, 2018 4:34 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: RASTETTER WILLIAM H June 5, 2018 4:34 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: Rosen Hugh June 5, 2018 4:34 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: PAPADOPOULOS STELIOS June 5, 2018 4:33 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: BALTIMORE DAVID June 5, 2018 4:30 PM - SEC Filing Form 4 Regulus Therapeutics For: Jun 01 Filed by: Collier Kathryn J June 5, 2018 4:30 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: WRIGHT TIMOTHY MICHAEL May 21, 2018 4:49 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Rosen Hugh May 21, 2018 4:47 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Witz Pascale May 21, 2018 4:46 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: RASTETTER WILLIAM H May 21, 2018 4:45 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: PAPADOPOULOS STELIOS May 21, 2018 4:45 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Deeg Mark Albert May 21, 2018 4:44 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Hagan Joseph P May 21, 2018 4:43 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Collier Kathryn J May 21, 2018 4:43 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: BALTIMORE DAVID May 21, 2018 4:42 PM - SEC Filing Form 4 Regulus Therapeutics For: May 17 Filed by: Chevallard Daniel R. May 21, 2018 4:42 PM - SEC Filing Form 10-Q Regulus Therapeutics For: Mar 31 May 10, 2018 5:17 PM - SEC Filing Form 8-K Regulus Therapeutics For: May 10 May 10, 2018 4:37 PM - SEC Filing Regulus Therapeutics (RGLS) Reports In-Line Q1 EPS May 10, 2018 4:15 PM - StreetInsider Regulus Reports First Quarter 2018 Financial Results and Pipeline Progress May 10, 2018 4:10 PM - PR NewsWire Regulus to Provide First Quarter 2018 Financial Results on May 10, 2018 May 3, 2018 4:16 PM - PR NewsWire Regulus Therapeutics (RGLS) Begins Multiple Ascending Dose Study in Healthy Volunteers of RGLS4326 for the Treatment of ADPKD May 1, 2018 8:41 AM - StreetInsider Regulus Initiates Multiple Ascending Dose Study in Healthy Volunteers of RGLS4326 for the Treatment of ADPKD May 1, 2018 8:30 AM - PR NewsWire Form 8-K Regulus Therapeutics For: Apr 23 April 27, 2018 4:12 PM - SEC Filing Form DEFA14A Regulus Therapeutics April 20, 2018 4:12 PM - SEC Filing Form DEF 14A Regulus Therapeutics For: Jun 01 April 20, 2018 4:07 PM - SEC Filing Form 4 Regulus Therapeutics For: Apr 14 Filed by: Collier Kathryn J April 17, 2018 4:37 PM - SEC Filing Form 3 Regulus Therapeutics For: Apr 14 Filed by: Collier Kathryn J April 17, 2018 4:35 PM - SEC Filing Form 8-K Regulus Therapeutics For: Apr 14 April 17, 2018 4:31 PM - SEC Filing Regulus Therapeutics (RGLS) Names Kathryn J. Collier to Board April 17, 2018 4:15 PM - StreetInsider Kathryn J. Collier Joins Regulus Board of Directors April 17, 2018 4:10 PM - PR NewsWire Form CT ORDER Regulus Therapeutics April 2, 2018 9:34 AM - SEC Filing B.Riley/FBR Starts Regulus Therapeutics (RGLS) at Neutral March 27, 2018 5:08 PM - StreetInsider Form 8-K Regulus Therapeutics For: Mar 20 March 22, 2018 4:06 PM - SEC Filing Full Article List